Top Story

Sex hormones fail to influence all-cause, CVD mortality in middle-aged men

September 30, 2016

Mortality and cardiovascular disease outcomes are not influenced by testosterone, dihydrotestosterone or estradiol in predominantly middle-aged men, study data show.

These data differ from previously reported findings revealing a link between hormones and CVD, the researchers wrote.

In the Journals

Majority of adverse events in clinical trials remain unpublished

September 30, 2016
A lower number and smaller range of adverse events were reported in published studies compared with those unpublished, according to data published in PLoS Medicine
In the Journals Plus

Better compliance with vaginal tablets than creams among postmenopausal women

September 30, 2016
Postmenopausal women were more likely to regularly fill their prescription for vaginally administered local estrogen therapy when prescribed vaginal tablets vs. creams…
In the Journals Plus

Parity number influences body size phenotype in postmenopausal women

September 30, 2016
Korean women who have given birth to three or more children are more likely to have metabolically abnormal obesity after menopause than women who delivered fewer…
In the Journals Plus

Type 1 diabetes often accompanied by other autoimmune diseases

September 29, 2016
People with type 1 diabetes may also be more likely to have a diagnosis of another autoimmune disease, study data show. Janet B. McGill, MD, FACE, professor of…
More News Headlines »
CME Video

Secondary Prevention of Atherothrombotic Events: Current Insights on Advancing Science

This activity is supported by an educational grant from Merck & Co.

Prevention of cardiovascular disease (CVD) is critical in light of its associated mortality, morbidity, and economic…
More »
Meeting News Coverage

VIDEO: Possible mechanism for why empagliflozin improves cardiovascular outcomes identified

September 9, 2016
More »
ATA 2016

ATA 2016


Obesity Consults® ObesityForum® 2015 Highlights

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Novo Nordisk, Inc.

Obesity has increased dramatically in the past 20 years and is considered a health care epidemic in the United States…
More »
in the journals

Get the best of the journals.
Read abstracts, search and filter results, gain perspective, view graphics.

Go »
Current Issues
View the Current Issues